Galderma

Galderma is a global pharmaceutical leader founded in 1981, specializing exclusively in dermatological science and skin health. The company operates as a pure-play dermatology entity, integrating advanced research with consumer-driven solutions to address a wide spectrum of medical and aesthetic skin conditions. By focusing on the full spectrum of skin health, Galderma provides innovative treatments that cater to both clinical prescription needs and daily skincare requirements.

The organization maintains a robust operational footprint with 17 global locations and a workforce of 5,000-10,000 employees. Galderma’s business model is structured across three primary segments: injectable aesthetics, dermatological skincare, and therapeutic dermatology. These divisions leverage scientific innovation to deliver high-quality care, including flagship products like Cetaphil. The company’s commitment to safety monitoring and rigorous training programs ensures that healthcare professionals can provide effective, science-based care tailored to individual patient journeys across diverse geographic markets.

Galderma’s strategic focus on medical and aesthetic innovation positions it as a key player in the global healthcare sector. The company continues to expand its reach through international partnerships and a deep commitment to dermatological research. Meet Galderma's team to learn more about the leadership and organizational structure driving these advancements. With a heritage spanning over four decades, Galderma remains dedicated to advancing skin health for individuals at every stage of life, consistently delivering value through its specialized therapeutic and consumer-facing product portfolios.